Hearing Aids for Hearing Loss

Overseen By Research Audiologist

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Sonova AG

Disqualifiers: Normal hearing, Cognitive impairment, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 6 weeks

20 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to learn how hearing instruments perform in varying environmental settings in adults with hearing loss. The main questions it aims to answer are: How do varying versions of hearing instrument features perform based on exposure to different environments? What is the hearing instrument user preference between varying versions of hearing instrument features? Participants will be fit with hearing instruments in the lab, and asked to wear them for the duration of the study period in their home environment. Participants will be asked to answer questionnaires throughout the study period.

Eligibility Criteria

This trial is for adults aged 18-95 with N4 hearing loss who have used hearing aids before and can speak, read, and write English fluently. They should be able to complete complex listening tasks without cognitive impairments. People with normal hearing or outside the specified range, no experience with hearing aids, or any condition that affects study participation are excluded.

Inclusion Criteria

Experienced hearing aid user

English fluency

I have severe hearing loss.

Exclusion Criteria

No hearing aid experience

Unable to speak, read, or write English fluently

Cognitive impairment

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are fit with hearing instruments and wear them in their home environment

6 weeks

Initial fitting visit (in-person), ongoing home use

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Hearing Instrument

Trial Overview The trial is testing how different features of a new hearing instrument perform in various environments. Adults with hearing loss will use these instruments at home and provide feedback through questionnaires about their preferences and the performance of the device's features.

Participant Groups

Group I: Hearing Aid Users Experimental Treatment 1 Intervention

Participants will wear hearing instruments for the duration of the study period. They will be asked to complete questionnaires about their environment and experience.

Who Is Running the Clinical Trial?

Sonova AG

Lead Sponsor

Trials

84

Recruited

2,000+

Arnd Kaldowski

Sonova AG

Chief Executive Officer since 2018

MBA from INSEAD, MSc in Mechanical Engineering from ETH Zurich

Stefan Launer

Sonova AG

Chief Medical Officer since 2016

PhD in Natural Sciences from ETH Zurich